The Immuno-Oncology and ADCs Market is witnessing strong expansion as cancer treatment paradigms increasingly shift toward targeted, immune-based therapies with improved efficacy and safety profiles. Immuno-oncology therapies harness the body’s immune system to identify and destroy cancer cells, while antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies wit... https://www.databridgemarketresearch.com/reports/global-immuno-oncology-and-adcs-market